NASDAQ · Shell Companies · USD

Archimedes Tech SPAC Partners III Co. (ARCI) Stock Analysis

Archimedes Tech SPAC Partners III Co. (ARCI) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

ARCI

$10.10

−$0.01 (−0.10%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ARCI with… →

ARCI Key Statistics

As of Sep 4, 2026

Trading

Open: $10.11
Previous Close: $10.11
Day's Range: 10.10–10.11
52-Week Range: 9.83–10.20
Volume: 150.00K

Valuation

Market Cap: $356.15M

Financials (FY)

Profit margin: 0.00%
Shares Outstanding: 35.26M

Dividend and dates

Avg Volume: 29.69K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ARCI Valuation vs Shell Companies Median

Median of 587 stocks

Metric	ARCI	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Archimedes Tech SPAC Partners III Co. (ARCI) is capitalised at $356.15M on the latest close. The company sits in the Financial Services sector, in the Shell Companies industry.

The most recent close on file for ARCI is $10.10, dated September 4, 2026. That is −$0.01 (−0.10%) against the previous close. Over the past 52 weeks the price has ranged from $9.83 to $10.20. The latest close sits 2.75% above that 52-week low.

Financial Health

Profit margin runs at 0%.

Growth & Income

The record shows no dividend for ARCI.

So far in 2026 the price is +2.54%.

Peer Comparison

Archimedes Tech SPAC Partners III Co. (ARCI) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Archimedes Tech SPAC Partners III Co.	ARCI	$356.15M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Archimedes Tech SPAC Partners III Co. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Archimedes Tech SPAC Partners III Co.

Archimedes Tech SPAC Partners III Co. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Claymont, Delaware.

Visit website →